Andere Sprachen Oxford BioDynamics Plc

Aktien

A2DH0R

GB00BD5H8572

OBD

Verzögert London S.E. Andere Börsenplätze 11:23:41 01.05.2024			% 5 Tage	% 1. Jan.
8,48 ^GBX	-0,70 %		-6,71 %	-69,71 %

03.04.	Oxford BioDynamics erreicht "wichtigen Meilenstein" mit neuem Labor	AN
03.04.	Oxford BioDynamics Plc eröffnet klinische Testeinrichtung in Großbritannien zur Durchführung des EpiSwitch Prostata-Screening (PSE) Bluttests	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Oxford BioDynamics reaches "important milestone" with new laboratory	03.04.
Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test	03.04.
Oxford Biodynamics Raises GBP9.9 Million to Support EpiSwitch Product Line	14.03.
FireAngel CFO resigns; ECR Minerals raises GBP585,000	14.03.
EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal	13.03.
Oxford BioDynamics plunges as annual loss widens; revenue up	17.01.
Oxford BioDynamics plunge as annual profit rises; revenue up	17.01.
Oxford BioDynamics shares plunge as annual revenue widens; revenue up	17.01.
AIM WINNERS & LOSERS: James Cropper falls on lower outlook	17.01.
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Revenue GBP510,000	17.01.
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Loss GBX-7.30	17.01.
Oxford BioDynamics Plc Reports Earnings Results for the Full Year Ended September 30, 2023	17.01.
Oxford BioDynamics Appoints Steven Arrivo as Senior Vice President of Business and Corporate Development	08.11.
FTSE 100 Edged Lower, Buoyed by Resilient Retail Sector	07.11.
Oxford BioDynamics director sells over 700,000 shares	20.10.23
Oxford BioDynamics Plc - Bupa UK to cover EpiSwitch CiRT for customers with cancer	19.10.23
Oxford BioDynamics Strikes Deal with Bupa for Access to Blood Test	18.10.23
Bupa UK to cover EpiSwitch® CiRT for customers with cancer	18.10.23
Oxford BioDynamics in deal with Bupa to expand blood test access	18.10.23
Oxford BioDynamics, Plc Announces a Strategic Agreement to Give Bupa Patients Access to OBD'sEpiSwitch CiRT	18.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Oxford BioDynamics Plc

Aktien

A2DH0R

GB00BD5H8572

OBD

Andere Sprachen

Filter